TTrialPathMatch Me to Trials
← Back to trials
RecruitingGeneral AnesthesiaAgedIntraoperative Hypotension

Remimazolam Versus Midazolam for General Anesthesia Induction in Elderly Patients Undergoing Non-Cardiac Surgery

Eligible age

65+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This prospective observational cohort study evaluates the effectiveness and safety of two benzodiazepine sedatives-remimazolam and midazolam-used for general anesthesia induction in elderly patients (≥65 years) undergoing elective non-cardiac surgery. Elderly patients have reduced organ reserve and altered pharmacokinetics/pharmacodynamics, increasing their susceptibility to anesthesia-related complications such as intraoperative hypotension, delayed emergence, and postoperative delirium. Remimazolam, an ultra-short-acting benzodiazepine metabolized by organ-independent tissue esterases, is hypothesized to offer greater hemodynamic stability, faster recovery, and a more favorable safety profile than midazolam in this vulnerable population. Investigators prospectively observe and collect data without altering routine clinical care; the choice of sedative is made by the attending anesthesiologist according to standard practice. Propensity score methods will be used to reduce confounding by indication.

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine

You may qualify if…

  • ✓ 1. Age 65 years or older.
  • ✓ 2. Scheduled for elective non-cardiac surgery under general anesthesia.
  • ✓ 3. American Society of Anesthesiologists physical status I to IV.
  • ✓ 4. Planned airway management with tracheal intubation or a laryngeal mask airway.
  • ✓ 5. Written informed consent provided by the participant or the participant's legally authorized representative.
  • ✓ \-

You may not qualify if…

  • ✕ 1. Long-term preoperative benzodiazepine use.
  • ✕ 2. Known allergy or contraindication to benzodiazepines, flumazenil, opioids, naloxone, or related drugs.
  • ✕ 3. History of drug abuse or alcoholism within the past 2 years.
  • ✕ 4. No preoperative cognitive assessment available.
  • ✕ 5. Preoperative cognitive impairment, defined as a Mini-Mental State 6.Examination score less than 18.
  • ✕ 7.Refusal to provide informed consent.
  • ✕ \-

Source: ClinicalTrials.gov · NCT07746505 · last updated 2026-08-05